n.a. (CHTP)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)
Chelsea Therapeutics International's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Chelsea Therapeutics International's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Chelsea Therapeutics International's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Chelsea Therapeutics' CEO Presents FDA Advisory Committee Update - Conference Call (Transcript)

Chelsea Therapeutics' CEO Presents FDA Advisory Committee Update - Conference Call (Transcript)

Chelsea Therapeutics' CEO Presents FDA Advisory Committee Update - Conference Call (Transcript)

Wednesday's Top 10 Articles, Videos on TheStreet

Wednesday's Top 10 Articles, Videos on TheStreet

These stories made today's top 10 list of articles and videos on TheStreet.

Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon

Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon

Biotech columnist Adam Feuerstein responds to biotech stock questions posed by his Twitter followers.

Monday's Top 10 Articles, Videos on TheStreet

Monday's Top 10 Articles, Videos on TheStreet

These stories made today's top 10 list of articles and videos on TheStreet.

Five Reasons Chelsea Therapeutics' Northera Will Get FDA Approval

Five Reasons Chelsea Therapeutics' Northera Will Get FDA Approval

Last week's positive panel sets up Chelsea nicely for an FDA approval in late March.

5 Stocks Under $5 Making Big Moves

5 Stocks Under $5 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Chelsea Therapeutics: FDA Panel Live Blog

Chelsea Therapeutics: FDA Panel Live Blog

An FDA panel meets today to review Chelsea's hypotension drug Northera.

Thursday's Top 10 Articles, Videos on TheStreet

Thursday's Top 10 Articles, Videos on TheStreet

These stories made today's top 10 list of articles and videos on TheStreet.

Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Chelsea Therapeutics International, Ltd.

Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Chelsea Therapeutics International, Ltd.

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Chelsea Therapeutics International, Ltd.

Biotech Stock Mailbag: Vivus, Chelsea, BioCryst

Biotech Stock Mailbag: Vivus, Chelsea, BioCryst

Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.

These Drugs Stocks Will Win FDA Approval

These Drugs Stocks Will Win FDA Approval

Contestants in TheStreet's FDA Drug-Approval Contest forecast their winners and losers.

BIO CEO Conference Live Blog

BIO CEO Conference Live Blog

Follow all the biotech news and social media conversation from the 2012 BIO CEO & Investor Conference.

5 Stocks Insiders Are Loading Up On

5 Stocks Insiders Are Loading Up On

Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.

Play TheStreet's FDA Drug-Approval Contest

Play TheStreet's FDA Drug-Approval Contest

The FDA will issue approval decisions on 17 drugs over the next four months. How well can you predict which drugs will be approved or rejected?

27 Hot Drugs Facing FDA Approval in 2012

27 Hot Drugs Facing FDA Approval in 2012

These are the biotech and drug stocks facing key FDA drug approval decisions in 2012.

A Roundup of Insider Buys

A Roundup of Insider Buys

Here are the industries and stocks that have seen heavy insider buying in the past two weeks.

22 Hot Drugs Facing FDA Approval in 2012

22 Hot Drugs Facing FDA Approval in 2012

These are the biotech and drug stocks facing key FDA drug approval decisions in 2012.

Chelsea Therapeutics International's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Chelsea Therapeutics International's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Chelsea Therapeutics International's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Chelsea Therapeutics International CEO Discusses Q2 2011 Results - Earnings Call Transcript.

Chelsea Therapeutics International CEO Discusses Q2 2011 Results - Earnings Call Transcript.

Chelsea Therapeutics International CEO Discusses Q2 2011 Results - Earnings Call Transcript.

5 Stocks That Could Pop on Earnings

5 Stocks That Could Pop on Earnings

These heavily shorted stocks could get squeezed higher if they report positive earnings this week.

5 Stocks Setting Up to Break Out

5 Stocks Setting Up to Break Out

These stocks look poised to break out and trade higher from current prices.

Chelsea Therapeutics International CEO Discusses Q1 2011 Results - Earnings Call Transcript

Chelsea Therapeutics International CEO Discusses Q1 2011 Results - Earnings Call Transcript

Chelsea Therapeutics International CEO Discusses Q1 2011 Results - Earnings Call Transcript

Chelsea Therapeutics CEO Discusses Q4 2010 Results - Earnings Call Transcript

Chelsea Therapeutics CEO Discusses Q4 2010 Results - Earnings Call Transcript

Chelsea Therapeutics CEO Discusses Q4 2010 Results - Earnings Call Transcript

Chelsea Therapeutics Reports Fourth Quarter And Full Year 2010 Results

Chelsea Therapeutics Reports Fourth Quarter And Full Year 2010 Results

Company to Host Conference Call at 4:30 PM ET